[Expression and Clinical Significance of PD-1 and PD-L1 in Pulmonary Carcinoids].

about

[Expression and Clinical Significance of PD-1 and PD-L1 in Pulmonary Carcinoids].

Item

http://www.wikidata.org/entity/Q55440787

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

[Expression and Clinical Significance of PD-1 and PD-L1 in Pulmonary Carcinoids].

@en

[Expression and Clinical Significance of PD-1 and PD-L1 in Pulmonary Carcinoids].

@nl

type

Item

label

[Expression and Clinical Significance of PD-1 and PD-L1 in Pulmonary Carcinoids].

@en

[Expression and Clinical Significance of PD-1 and PD-L1 in Pulmonary Carcinoids].

@nl

prefLabel

[Expression and Clinical Significance of PD-1 and PD-L1 in Pulmonary Carcinoids].

@en

[Expression and Clinical Significance of PD-1 and PD-L1 in Pulmonary Carcinoids].

@nl

P1476

[Expression and Clinical Significance of PD-1 and PD-L1 in Pulmonary Carcinoids].

@en

P2093

Haiyang Fan

http://www.w3.org/2001/XMLSchema#string

Hongyi Zhang

http://www.w3.org/2001/XMLSchema#string

Hongyu Liu

http://www.w3.org/2001/XMLSchema#string

Mingbiao Li

http://www.w3.org/2001/XMLSchema#string

Minghui Liu

http://www.w3.org/2001/XMLSchema#string

Song Xu

http://www.w3.org/2001/XMLSchema#string

Ying Li

http://www.w3.org/2001/XMLSchema#string

Yongwen Li

http://www.w3.org/2001/XMLSchema#string

P2860

The blockade of immune checkpoints in cancer immunotherapy

Challenges in the Diagnosis and Management of Well-Differentiated Neuroendocrine Tumors of the Lung (Typical and Atypical Carcinoid): Current Status and Future Considerations

Bronchopulmonary neuroendocrine tumors

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

Advances in neuroendocrine lung tumors.

Programmed death ligand-1 expression in non-small cell lung cancer.

Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma.

Clinical applications of PD-1-based therapy: a focus on pembrolizumab (MK-3475) in the management of melanoma and other tumor types

PD-1 expression on dendritic cells suppresses CD8(+) T cell function and antitumor immunity

P304

847-853

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3779/J.ISSN.1009-3419.2016.12.07

http://www.w3.org/2001/XMLSchema#string

P407

Chinese

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jun Chen

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27978870

http://www.w3.org/2001/XMLSchema#string

P932

5973451

http://www.w3.org/2001/XMLSchema#string